Navigation Links
DSS Research Moves Corporate Office
Date:9/17/2007

FORT WORTH, Texas, Sept. 17 /PRNewswire/ -- DSS Research, a national research and consulting firm serving health insurance carriers, hospitals and medical products/pharma companies, moved its corporate office in late August. "We needed a new location to bring our three major operations groups together in one location, to generally support our growing business and to provide a more efficient working environment for all of our Texas employees," according to Roger Gates, CEO. DSS currently has more than 250 employees in the Fort Worth area and smaller numbers in the Washington, DC and Santa Fe, New Mexico offices.

The Corporate office can be reached at 800.989.5150 or 817.665.7000. The address is: DSS Research, 4150 International Plaza, Suite 900, Fort Worth, Texas 76109.

About DSS Research

DSS Research is a national marketing research firm specializing in health insurance and health care. Over the past 23 years, DSS has conducted research and provided insight for health insurance organizations across the country. The firm's services include product development, satisfaction research, brand analysis and strategy research, ad testing and tracking, market segmentation research and health risk assessment. This gives DSS a high-level view of the evolving health insurance industry. DSS employs more than 200 health care market research specialists. For more information, please visit http://www.dssresearch.com.


'/>"/>
SOURCE DSS Research
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Stem cell research- now Nobel Laureates join the debate
3. Researchers urge caution in using ear tube surgery
4. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
5. Spouses and other partners lower blood pressure says new research
6. Researchers Scale to assess the Severity of Epilepsy in Kids
7. More Research Required For COPD
8. Researchers identify the early makers of Neonatal Sepsis
9. OHSU Researchers Announce New Discovery
10. Skin Cancer Research To Go Global
11. Researchers Identify Gene Connected To Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) ... per workers’ compensation claim in 2013 and 2014, according to CompScope™ Medical Benchmarks ... (WCRI) . , According to the study, medical payments per claim in California decreased ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... financial planning services from offices headquartered in Little Rock, has initiated a charity ... According to the National Foundation to End Senior Hunger, Arkansas ranks first in ...
(Date:12/8/2016)... FL (PRWEB) , ... December 08, 2016 , ... Coppin ... business owners and families in and around the Cape Coral area, is embarking on ... Chapin Food Bank of Southwest Florida. , The Harry Chapin Food Bank of Southwest ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication to ... of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of ... both sides of the Atlantic with a mechanism to comply with EU data protection ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the drug in their bodies, a researcher at the Icahn School of Medicine ... Research. , The study found that when young children are exposed to secondhand ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Agenovir Corporation, a company ... antiviral therapeutics, today announced that it appointed ... and a member of the board of directors. ... with a deep background in both founding and ... of Agenovir, co-president of Chan Zuckerberg  Biohub ...
(Date:12/8/2016)... NORWALK, Conn. , Dec. 8, 2016   Mederi Therapeutics Inc . has ... for Stretta Therapy, a non-surgical treatment for chronic gastroesophageal reflux disease (GERD). ... ... procedure performed and broadcast during the Chinese Congress of Digestive Endoscopy, by Professor Jun ... , , "We ...
(Date:12/8/2016)... ANTONIO , Dec. 8, 2016 Eli ... announced that the neoMONARCH study of abemaciclib, a cyclin-dependent ... primary endpoint of reducing expression of Ki67, a biomarker ... data from the Phase 2 trial presented during the ... Cancer Symposium (SABCS) evaluated abemaciclib, both alone or in ...
Breaking Medicine Technology: